MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 287 filers reported holding MYRIAD GENETICS INC in Q1 2014. The put-call ratio across all filers is 2.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $3,780,000 | -25.6% | 111,205 | -22.6% | 0.02% | -24.1% |
| Q1 2015 | $5,084,000 | +15.2% | 143,607 | +10.8% | 0.03% | +7.4% |
| Q4 2014 | $4,414,000 | -7.9% | 129,589 | +4.2% | 0.03% | +8.0% |
| Q3 2014 | $4,795,000 | -5.3% | 124,309 | -4.4% | 0.02% | +8.7% |
| Q2 2014 | $5,061,000 | -11.8% | 130,025 | -22.5% | 0.02% | -17.9% |
| Q1 2014 | $5,740,000 | +36.1% | 167,882 | -16.5% | 0.03% | +33.3% |
| Q4 2013 | $4,217,000 | -5.9% | 201,001 | +5.4% | 0.02% | -8.7% |
| Q3 2013 | $4,483,000 | -11.0% | 190,754 | +1.7% | 0.02% | -14.8% |
| Q2 2013 | $5,039,000 | – | 187,519 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
| Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
| Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
| PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
| EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
| Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
| AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
| Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
| Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |